Intratracheal surfactant administration preserves airway compliance during lung reperfusion.

[1]  R. Novick,et al.  Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. , 1994, The Journal of thoracic and cardiovascular surgery.

[2]  J. J. Batenburg,et al.  The Pulmonary Surfactant System , 1994 .

[3]  J. Johansson,et al.  The proteins of the surfactant system. , 1994, The European respiratory journal.

[4]  E. Pattishall,et al.  Other uses of surfactant. , 1993, Clinics in perinatology.

[5]  R. Novick,et al.  Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. , 1993, The American review of respiratory disease.

[6]  A. Jobe,et al.  Pulmonary surfactant therapy. , 1993, The New England journal of medicine.

[7]  A. M. Lefer,et al.  Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. , 1993, Annual review of pharmacology and toxicology.

[8]  Arthur S Slutsky,et al.  THE EFFECT OF PGE1 AND TEMPERATURE ON LUNG FUNCTION FOLLOWING PRESERVATION , 1991, Transplantation.

[9]  S. Matalon,et al.  Characterization of antioxidant activities of pulmonary surfactant mixtures. , 1990, Biochimica et biophysica acta.

[10]  W. Klepetko,et al.  Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application. , 1990, The Journal of thoracic and cardiovascular surgery.

[11]  J. Benfield,et al.  Effect of immunosuppression and lung transplantation upon surfactant. , 1974, Surgery.

[12]  P. Thomas,et al.  Preservation of pulmonary surfactant activity in canine lung allografts by immune suppressive therapy. , 1968, The Journal of thoracic and cardiovascular surgery.